Names and pronunciation
(pol′a-tooz′ue-mab ve-doe′tin) Polivy
PDF page 1063
Drug reference
(pol′a-tooz′ue-mab ve-doe′tin) Polivy
PDF page 1063
Func. class.: Antineoplastic, antibody drug conjugate
PDF page 1063
USES: Treatment of relapsed/ refractory diffuse large B-cell lymphoma (in combination with bendamustine and rituximab), after at least 2 prior therapies
PDF page 1063
CONTRAINDICATIONS Hypersensitivity
PDF page 1063
DOSAGE AND ROUTES Diffuse large B-cell lymphoma, relapsed or refractory. • Adult: IV: 1.8 mg/kg q21 days × 6 cy- cles (in combination with bendamustine and rituximab)
PDF page 1063
Available forms: Injection 30, 140 mg single-use vials
PDF page 1063
• Adult: IV: 1.8 mg/kg q21 days × 6 cy- cles (in combination with bendamustine and rituximab)
PDF page 1063